Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.

作者: Céline Frochot , Benoît Di Stasio , Régis Vanderesse , Marie-Josée Belgy , Marc Dodeller

DOI: 10.1016/J.BIOORG.2006.11.005

关键词:

摘要: Destruction of the neovasculature is essential for tumor eradication by photodynamic therapy. Since over-expression integrins correlated with angiogenesis, we conjugated a photosensitizer (5-(4-carboxyphenyl)-10,15,20-triphenylchlorin or porphyrin) to αvβ3 integrin specific peptide RGD (H-Arg-Gly-Asp-OH) motif as common sequence. We reported an efficient solid-phase synthesis new family peptidic photosensitizers linear cyclic[RGDfK] and compared conjugates in vitro selectivity activity. The were characterized 1H NMR, MALDI, UV–visible spectroscopy singlet oxygen formation was performed. Chlorins containing constrained incorporated up 98- 80-fold more, respectively, than unconjugated over 24-h exposure human umbilical vein endothelial cells (HUVEC) over-expressing integrin. Peptidic moiety also led non-specific increased cellular uptake murine mammary carcinoma (EMT-6), lacking binding receptors. Survival measurements demonstrated that HUVEC greatly sensitive conjugates-mediated

参考文章(35)
Raphaël Schneider, Frédéric Schmitt, Céline Frochot, Yves Fort, Natacha Lourette, François Guillemin, Jean-François Müller, Muriel Barberi-Heyob, Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy Bioorganic & Medicinal Chemistry. ,vol. 13, pp. 2799- 2808 ,(2005) , 10.1016/J.BMC.2005.02.025
Elke Bergmann-Leitner, Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner] Current Pharmaceutical Design. ,vol. 15, pp. 730- 731 ,(2005) , 10.2174/138161208784246207
Gordon C. Tucker, Integrins: Molecular targets in cancer therapy Current Oncology Reports. ,vol. 8, pp. 96- 103 ,(2006) , 10.1007/S11912-006-0043-3
Loraine Tirand, Céline Frochot, Régis Vanderesse, Noémie Thomas, Eric Trinquet, Sophie Pinel, Marie-Laure Viriot, François Guillemin, Muriel Barberi-Heyob, A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells Journal of Controlled Release. ,vol. 111, pp. 153- 164 ,(2006) , 10.1016/J.JCONREL.2005.11.017
Judah Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Medicine. ,vol. 1, pp. 27- 31 ,(1995) , 10.1038/NM0195-27
Shinya Oishi, Takae Kamano, Ayumu Niida, Yoshihiko Odagaki, Nobuyuki Hamanaka, Mikio Yamamoto, Keiichi Ajito, Hirokazu Tamamura, Akira Otaka, Nobutaka Fujii, Diastereoselective Synthesis of Newψ[(E)-CHCMe]- andψ[(Z)-CHCMe]-type Alkene Dipeptide Isosteres by Organocopper Reagents and Application to Conformationally Restricted Cyclic RGD Peptidomimetics The Journal of Organic Chemistry. ,vol. 67, pp. 6162- 6173 ,(2002) , 10.1021/JO025923M
Thierry Patrice, David Olivier, Ludovic Bourre, PDT in clinics: indications, results, and markets. Journal of Environmental Pathology Toxicology and Oncology. ,vol. 25, pp. 467- 485 ,(2006) , 10.1615/JENVIRONPATHOLTOXICOLONCOL.V25.I1-2.300
W Sharman, Targeted photodynamic therapy via receptor mediated delivery systems. Advanced Drug Delivery Reviews. ,vol. 56, pp. 53- 76 ,(2004) , 10.1016/J.ADDR.2003.08.015
Susan J. Bogdanowich-Knipp, Soma Chakrabarti, Teruna J. Siahaan, Todd D. Williams, Robert K. Dillman, Solution stability of linear vs. cyclic RGD peptides Journal of Peptide Research. ,vol. 53, pp. 530- 541 ,(1999) , 10.1034/J.1399-3011.1999.00052.X
Catherine F McCusker, Philip J Kocienski, F.Thomas Boyle, Andreas G Schätzlein, Solid-phase synthesis of c(RGDfK) derivatives: on-resin cyclisation and lysine functionalisation Bioorganic & Medicinal Chemistry Letters. ,vol. 12, pp. 547- 549 ,(2002) , 10.1016/S0960-894X(01)00799-5